Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 108
11
Diseases
43
Unique genes
0.242
Avg. similarity score
11p11.2 deletion syndrome
Most-connected disease (6 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
11p11.2 deletion syndrome
Potocki-shaffer syndrome
Parietal foramina
Seizures, scoliosis, and macrocephaly/microcephaly syndrome
exostoses, multiple, type 2
Frontonasal dysplasia with alopecia and genital anomaly
Posterior cortical atrophy
Exostoses
Intellectual developmental disorder behavioral dysmorphic
craniosynostosis 2
combined immunodeficiency due to ZAP70 deficiency
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| 11p11.2 deletion syndrome | 6 | 6 | 3 |
| Potocki-shaffer syndrome | 6 | 6 | 3 |
| Parietal foramina | 5 | 5 | 2 |
| Seizures, scoliosis, and macrocephaly/microcephaly syndrome | 4 | 4 | 1 |
| exostoses, multiple, type 2 | 4 | 4 | 1 |
| Frontonasal dysplasia with alopecia and genital anomaly | 3 | 3 | 1 |
| Posterior cortical atrophy | 3 | 3 | 13 |
| Exostoses | 2 | 2 | 28 |
| Intellectual developmental disorder behavioral dysmorphic | 2 | 2 | 1 |
| craniosynostosis 2 | 2 | 2 | 1 |
| combined immunodeficiency due to ZAP70 deficiency | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| EXT2 | 5 / 11 | 11p11.2 deletion syndrome, Exostoses, exostoses, multiple, type 2, Potocki-shaffer syndrome and 1 more |
| ALX4 | 4 / 11 | 11p11.2 deletion syndrome, Frontonasal dysplasia with alopecia and genital anomaly, Parietal foramina, Potocki-shaffer syndrome |
| MSX2 | 3 / 11 | craniosynostosis 2, Parietal foramina, Posterior cortical atrophy |
| PHF21A | 3 / 11 | 11p11.2 deletion syndrome, Intellectual developmental disorder behavioral dysmorphic, Potocki-shaffer syndrome |
| ZAP70 | 2 / 11 | combined immunodeficiency due to ZAP70 deficiency, Posterior cortical atrophy |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Defective EXT2 causes exostoses 2 | Reactome | 2 / 14 | 39.9× | 1.11e-3 | 1.46e-2 ✓ sig. |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | Reactome | 2 / 14 | 39.9× | 1.11e-3 | 1.46e-2 ✓ sig. |
| Tie2 Signaling | Reactome | 2 / 18 | 31.0× | 1.85e-3 | 2.15e-2 ✓ sig. |
| Pink/Parkin Mediated Mitophagy | Reactome | 2 / 22 | 25.4× | 2.76e-3 | 2.90e-2 ✓ sig. |
| Glycosaminoglycan biosynthesis - heparan sulfate / heparin | KEGG | 2 / 24 | 23.3× | 3.29e-3 | 3.29e-2 ✓ sig. |
| HS-GAG biosynthesis | Reactome | 2 / 30 | 18.6× | 5.11e-3 | 4.44e-2 ✓ sig. |
| Mitophagy - animal | KEGG | 3 / 105 | 8.0× | 6.22e-3 | 5.06e-2 |
| Defective ABCA1 causes Tangier disease | Reactome | 1 / 2 | 140× | 7.15e-3 | 5.54e-2 |
| SDK interactions | Reactome | 1 / 2 | 140× | 7.15e-3 | 5.54e-2 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | Reactome | 1 / 3 | 93.1× | 1.07e-2 | 7.16e-2 |
| Catecholamine biosynthesis | Reactome | 1 / 4 | 69.8× | 1.42e-2 | 8.45e-2 |
| Serotonin and melatonin biosynthesis | Reactome | 1 / 5 | 55.9× | 1.78e-2 | 9.66e-2 |
| MET activates PTPN11 | Reactome | 1 / 5 | 55.9× | 1.78e-2 | 9.66e-2 |
| tRNA modification in the mitochondrion | Reactome | 1 / 6 | 46.6× | 2.13e-2 | 1.07e-1 |
| HDL assembly | Reactome | 1 / 8 | 34.9× | 2.83e-2 | 1.25e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| fluid transport | GO:0042044 | 2 / 3 | 290× | 1.55e-5 | 7.38e-4 ✓ sig. |
| outflow tract septum morphogenesis | GO:0003148 | 3 / 28 | 46.6× | 3.57e-5 | 1.40e-3 ✓ sig. |
| embryonic forelimb morphogenesis | GO:0035115 | 3 / 33 | 39.5× | 5.90e-5 | 2.03e-3 ✓ sig. |
| endochondral bone morphogenesis | GO:0060350 | 2 / 6 | 145× | 7.71e-5 | 2.50e-3 ✓ sig. |
| polysaccharide biosynthetic process | GO:0000271 | 2 / 7 | 124× | 1.08e-4 | 3.20e-3 ✓ sig. |
| vasodilation | GO:0042311 | 3 / 50 | 26.1× | 2.06e-4 | 5.16e-3 ✓ sig. |
| endochondral bone growth | GO:0003416 | 2 / 10 | 86.9× | 2.30e-4 | 5.57e-3 ✓ sig. |
| heparin proteoglycan biosynthetic process | GO:0030210 | 2 / 11 | 79.0× | 2.81e-4 | 6.41e-3 ✓ sig. |
| embryonic digit morphogenesis | GO:0042733 | 3 / 57 | 22.9× | 3.05e-4 | 6.79e-3 ✓ sig. |
| multicellular organismal-level water homeostasis | GO:0050891 | 2 / 12 | 72.4× | 3.36e-4 | 7.26e-3 ✓ sig. |
| heart development | GO:0007507 | 5 / 273 | 8.0× | 3.92e-4 | 8.09e-3 ✓ sig. |
| outflow tract morphogenesis | GO:0003151 | 3 / 63 | 20.7× | 4.09e-4 | 8.35e-3 ✓ sig. |
| osteoblast development | GO:0002076 | 2 / 16 | 54.3× | 6.08e-4 | 1.10e-2 ✓ sig. |
| mitochondrial fission | GO:0000266 | 2 / 16 | 54.3× | 6.08e-4 | 1.10e-2 ✓ sig. |
| sulfation | GO:0051923 | 2 / 16 | 54.3× | 6.08e-4 | 1.10e-2 ✓ sig. |